(1 - 28 von 45
)
Basilea's novel oncology drug candidate BAL : data presented at...
www.firmenpresse.de
Basilea Pharmaceutica AG /Basilea's novel oncology drug candidate BAL : data presented at international conference demonstrate dual mode ...
Investegate |Basilea Pharmaceutica AG Announcements | Basilea...
www.investegate.co.uk
Investegate announcements from Basilea Pharmaceutica AG, Basilea in-licenses targeted cancer therapy
BSLN.S - Basilea Pharmaceutica AG | Stock Price & Latest News |...
www.reuters.com
Laurenz Kellenberger: Member of the Management Committee, Chief Scientific Officer. Damian Heller: General Counsel, Corporate Secretary.
Basilea Pharmaceutica AG: Basilea announces licensing of a novel ...www.finanznachrichten.de › nachrichten
www.finanznachrichten.de
— Dr. Laurenz Kellenberger, Chief Scientific Officer of Basilea, said: "This agreement shows our commitment to implementing our new corporate ...
sortiert nach Relevanz / Datum